Biotech News

Nautilus Biotechnology Reports Third Quarter 2026 Financial Results

Nautilus Biotechnology (NAUT)Nautilus BiotechnologyEarnings

Nautilus Biotechnology, Inc. (NASDAQ: NAUT), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the third quarter ended September 30, 2026.

Related news

Nautilus Biotechnology

Single-Molecule Proteomics Platform Nautilus Biotechnology is a development-stage life sciences company building a single-molecule proteomics platform intended to make comprehensive protein analysis more accessible. The platform is designed to quantify proteins and their proteoforms at scale, supporting research in disease biology,...

Recent company news

Stock data

Close
2.17 USD
Market cap
340.57M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States